24 Sept 2026, 14:53
Meetings & Governance—
PIQPROTEOMICS INTERNATIONAL LABORATORIES LTD
Announcement history available from 1 August 2025
Fromto
23 Sept 2026, 09:58
Presentations—
14 Sept 2026, 09:47
Company UpdateMS
31 Aug 2026, 16:35
Financial ResultsMS
31 Aug 2026, 16:32
Company Administration—
13 Aug 2026, 08:46
Company UpdateMS
5 Aug 2026, 08:17
Substantial Holders—
27 July 2026, 09:48
Quarterly ReportsMS
23 July 2026, 09:29
Presentations—
22 July 2026, 08:30
Company UpdateMS
13 July 2026, 08:24
Securities Administration—
8 July 2026, 10:09
Company UpdateMS
7 July 2026, 09:07
Securities Administration—
3 July 2026, 17:28
ASX QueryMS
2 July 2026, 11:52
Securities Administration—
3 June 2026, 09:59
Securities Administration—
7 May 2026, 13:18
ASX QueryMS
1 May 2026, 10:07
Company Administration—
28 Apr 2026, 09:13
Quarterly ReportsMS
28 Apr 2026, 08:59
PresentationsMS
17 Apr 2026, 14:37
Director Interests—
17 Apr 2026, 09:21
Company AdministrationMS
25 Feb 2026, 08:43
Financial ResultsMS
23 Feb 2026, 16:32
Company Administration—
5 Feb 2026, 09:11
Company Administration—
2 Feb 2026, 10:42
Securities Administration—
30 Jan 2026, 08:25
Quarterly ReportsMS
21 Jan 2026, 15:30
Securities Administration—
19 Jan 2026, 10:05
Director Interests—
16 Jan 2026, 08:22
Company UpdateMS
16 Jan 2026, 08:20
Securities Administration—
14 Jan 2026, 08:44
Company AdministrationMS
12 Jan 2026, 10:23
Securities Administration—
9 Jan 2026, 11:08
Securities Administration—
24 Dec 2025, 10:15
Company UpdateMS
22 Dec 2025, 08:38
Securities Administration—
17 Dec 2025, 08:33
Company UpdateMS
16 Dec 2025, 08:45
Company Update—
15 Dec 2025, 08:21
Company UpdateMS
12 Dec 2025, 09:59
Presentations—
2 Dec 2025, 15:52
ASX QueryMS
26 Nov 2025, 09:58
Company UpdateMS
26 Nov 2025, 09:29
Securities Administration—
26 Nov 2025, 09:27
Securities Administration—
26 Nov 2025, 08:32
Director Interests—
26 Nov 2025, 08:29
Securities Administration—
24 Nov 2025, 08:37
Company UpdateMS
21 Nov 2025, 14:46
Meetings & Governance—
21 Nov 2025, 11:51
Company Administration—
18 Nov 2025, 10:55
Presentations—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 24 Sept 2026, 14:53 | Notice of AGM Date | Meetings & Governance | — | 08006 | |
| 23 Sept 2026, 09:58 | Investor Presentation | Presentations | — | 03026 | |
| 14 Sept 2026, 09:47 | PromarkerD and PromarkerEso Commercial Rollout Update | Company Update | MS | 11001 | |
| 31 Aug 2026, 16:35 | Appendix 4E and Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 31 Aug 2026, 16:32 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 13 Aug 2026, 08:46 | Australian patent for PromarkerEndo | Company Update | MS | 11001 | |
| 5 Aug 2026, 08:17 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 27 July 2026, 09:48 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 23 July 2026, 09:29 | Webinar Presentation - Healius distribution agreement | Presentations | — | 03026 | |
| 22 July 2026, 08:30 | Proteomics signs national distribution deal with Healius | Company Update | MS | 11001, 14014 | |
| 13 July 2026, 08:24 | Application for quotation of securities - PIQ | Securities Administration | — | 06020 | |
| 8 July 2026, 10:09 | US patent secured for PromarkerEndo | Company Update | MS | 11001 | |
| 7 July 2026, 09:07 | Notification of cessation of securities - PIQ | Securities Administration | — | 06027 | |
| 3 July 2026, 17:28 | Response to ASX Price Query | ASX Query | MS | 17003 | |
| 2 July 2026, 11:52 | Change of Registered Office Address | Securities Administration | — | 12003 | |
| 3 June 2026, 09:59 | Application for Quotation of Securities - PIQ | Securities Administration | — | 06020 | |
| 7 May 2026, 13:18 | Response to ASX Price Query | ASX Query | MS | 17003 | |
| 1 May 2026, 10:07 | Notification of Expiry of Listed Options - PIQO | Company Administration | — | 06009, 12008, 16002 | |
| 28 Apr 2026, 09:13 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 28 Apr 2026, 08:59 | Proteomics Strategic Plan | Presentations | MS | 03026 | |
| 17 Apr 2026, 14:37 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 17 Apr 2026, 09:21 | Restructure, Executive Appointment and Board Update | Company Administration | MS | 12001, 12008 | |
| 25 Feb 2026, 08:43 | Appendix 4D and Interim Financial Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 23 Feb 2026, 16:32 | Final Director's Interest Notice | Company Administration | — | 02010, 12001 | |
| 5 Feb 2026, 09:11 | Resignation of Joint Company Secretary | Company Administration | — | 12007 | |
| 2 Feb 2026, 10:42 | Application for quotation of securities - PIQ | Securities Administration | — | 06020 | |
| 30 Jan 2026, 08:25 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 21 Jan 2026, 15:30 | Application for quotation of securities - PIQ | Securities Administration | — | 06020 | |
| 19 Jan 2026, 10:05 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 16 Jan 2026, 08:22 | Canadian patent secured for PromarkerEso test for EAC | Company Update | MS | 11001 | |
| 16 Jan 2026, 08:20 | Application for quotation of securities - PIQ | Securities Administration | — | 06020 | |
| 14 Jan 2026, 08:44 | Appointment of CEO and Managing Director | Company Administration | MS | 12019 | |
| 12 Jan 2026, 10:23 | Application for quotation of securities - PIQ | Securities Administration | — | 06020 | |
| 9 Jan 2026, 11:08 | Notification of cessation of securities - PIQ | Securities Administration | — | 06027 | |
| 24 Dec 2025, 10:15 | Proteomics US lab CAP accredited - extends precision Dx lab | Company Update | MS | 11001 | |
| 22 Dec 2025, 08:38 | Application for quotation of securities - PIQ | Securities Administration | — | 06020 | |
| 17 Dec 2025, 08:33 | US patent secured for PromarkerEso diagnostic test for EAC | Company Update | MS | 11001 | |
| 16 Dec 2025, 08:45 | PromarkerD changes how Doctors manage DKD - study published | Company Update | — | 11001 | |
| 15 Dec 2025, 08:21 | PromarkerD predicts risk of DKD in Aboriginal Australians | Company Update | MS | 11001 | |
| 12 Dec 2025, 09:59 | Investor presentation - TSN ASX Gems Conference | Presentations | — | 03026 | |
| 2 Dec 2025, 15:52 | Response to ASX Price Query | ASX Query | MS | 17003 | |
| 26 Nov 2025, 09:58 | US Medicare sets reimbursement price for PromarkerD DKD test | Company Update | MS | 11001 | |
| 26 Nov 2025, 09:29 | Application for quotation of securities - PIQ | Securities Administration | — | 06020 | |
| 26 Nov 2025, 09:27 | Notification regarding unquoted securities - PIQ | Securities Administration | — | 06021 | |
| 26 Nov 2025, 08:32 | Change of Director's Interest Notice x3 | Director Interests | — | 02009 | |
| 26 Nov 2025, 08:29 | Notification of cessation of securities - PIQ | Securities Administration | — | 06027 | |
| 24 Nov 2025, 08:37 | OxiDx test correlates with superior racehorse performance | Company Update | MS | 11001 | |
| 21 Nov 2025, 14:46 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 21 Nov 2025, 11:51 | AGM Chair's Address and Company Presentation | Company Administration | — | 12008, 15002 | |
| 18 Nov 2025, 10:55 | Investor presentation - Bell Potter Healthcare Conference | Presentations | — | 03026, 15002 |
1–50 of 70
1 / 2